Risk Factors for Major Adverse Cardiovascular Events in Rheumatoid Arthritis Patients Treated with Tocilizumab

被引：0
|
作者：
Rao, Vijay [1 ]
Pavlov, Andrey [2 ]
Klearman, Micki [1 ]
Musselman, David [3 ]
Giles, Jon T. [4 ]
Bathon, Joan M. [4 ]
Sattar, Naveed [5 ]
Lee, Janet S. [3 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
[2] Everest, Toronto, ON, Canada
[3] Roche, Nutley, NJ USA
[4] Columbia Univ, Med Ctr, New York, NY USA
[5] Univ Glasgow, Glasgow, Lanark, Scotland
来源：
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1642
引用
收藏
页码：S642 / S642
页数：1
相关论文
共 50 条
  • [41] Tocilizumab and the Risk for Cardiovascular Disease Events Among Rheumatoid Arthritis Patients: A Direct Comparison in Real World Setting
    Xie, Fenglong
    Yun, Huifeng
    Levitan, Emily
    Muntner, Paul M.
    Curtis, Jeffrey R.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [42] TOCILIZUMAB AND THE RISK FOR CARDIOVASCULAR DISEASE EVENTS AMONG RHEUMATOID ARTHRITIS PATIENTS: A DIRECT COMPARISON IN REAL WORLD SETTING
    Xie, F.
    Yun, H.
    Levitan, E.
    Muntner, P.
    Curtis, J. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 145 - 146
  • [43] THE EFFECT OF ADALIMUMAB ON RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN RHEUMATOID ARTHRITIS: A META-ANALYSIS OF RANDOMIZED TRIALS
    Burmester, G.
    Emery, P.
    Signorovitch, J.
    Williams, D.
    Valdes, J.
    Bao, Y.
    Mulani, P. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 359 - 360
  • [44] Risk Factors for Leukopenia in Asian Patients with Rheumatoid Arthritis Undergoing Tocilizumab
    Kuo, Ping Hsuan
    Fang, Pu-Jun
    Chen, Ming-Han
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1070 - 1072
  • [45] Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis
    Cooksey, Roxanne
    Brophy, Sinead
    Kennedy, Jonathan
    Gutierrez, Fabiola Fernandez
    Pickles, Tim
    Davies, Ruth
    Piguet, Vincent
    Choy, Ernest
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2018, 48 (03) : 367 - 373
  • [46] Fatigue and Related Factors in Patients with Rheumatoid Arthritis Treated with Tocilizumab in Daily Clinical
    Corominas, H.
    Alegre de Miguel, C.
    Rodriguez-Gomez, M.
    Marras Fernandez-Cid, C.
    Maceiras Pan, F.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1032 - S1033
  • [47] The Prothrombotic State in Rheumatoid Arthritis: An Additive Risk Factor for Adverse Cardiovascular Events
    Bisoendial, Radjesh J.
    Levi, Marcel
    Tak, Paul-Peter
    Stroes, Eric S. G.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2010, 36 (04): : 452 - 457
  • [48] Incidence and risk factors of major cardiovascular events in rheumatoid arthritis and psoriatic arthritis: A population-based cohort study
    Meng, Huan
    Lam, Steven H.
    So, Ho
    Tam, Lai -Shan
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 65
  • [49] Risk of cardiovascular events and effect on mortality in patients with rheumatoid arthritis
    Nossent, H
    JOURNAL OF RHEUMATOLOGY, 2000, 27 (09) : 2282 - +
  • [50] RISK FACTORS FOR CARDIOVASCULAR DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS
    van Halm, V. P.
    Voskuyl, A. E.
    Lems, W. F.
    Steen, K. S.
    Dijkmans, B. A.
    RHEUMATOLOGY, 2002, 41 : 70 - 70
12345